# Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

> **NCT00407641** · PHASE4 · WITHDRAWN · sponsor: **Anemia Working Group Romania**

## Conditions studied

- Diabetes Mellitus
- Hemodialysis

## Interventions

- **DRUG:** Tinzaparin administration
- **DRUG:** Heparin administration

## Key facts

- **NCT ID:** NCT00407641
- **Lead sponsor:** Anemia Working Group Romania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2015-01
- **Final completion:** 2017-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Financial and administrative matters did not allow collaboration among centers.
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407641, "Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00407641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*